「japan」の検索結果
79件：46～50件目を表示
-
maged, leading to progressive visual field loss, and if left untreated, can result in blindness. In Japan, glaucoma is reported to be the leading cause of visual impairment (including reduced vision a...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904_0.pdf -
千寿製薬株式会社
NEWS & RELEASE August 20, 2026 Senju initiated Phase III Clinical Trials in Japan for "SJP-0049" for the treatment of Allergic Conjunctivitis（PDF） June 1, 2026 Launch of Distribution of ...
http://www.senju.co.jp/english/ -
al Co., Ltd. Launch of Distribution of RET-700 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distributi...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726_0.pdf -
maged, leading to progressive visual field loss, and if left untreated, can result in blindness. In Japan, glaucoma is reported to be the leading cause of visual impairment (including reduced vision a...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf -
Distribution of Software for Dry-eye Analysis Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distributi...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906.pdf